Setting a National Psychedelic Policy Agenda

This is a past event

Event Description

As the psychedelic renaissance unfolds, groups are forming to identify national policy priorities. This event assembled a panel of experts from several of these groups for a discussion on setting a national psychedelic policy agenda.

Panelists

  • Introduction: Carmel Shachar, Executive Director, The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School
  • Ismail Lourido Ali, Director and Counsel, Policy & Advocacy, Multidisciplinary Association for Psychedelic Studies
  • Ariel Clark, Partner, Clark Howell LLP; Founding Board Member, Psychedelic Bar Association; General Legal Counsel and Board Member, Chacruna Institute for Psychedelic Plant Medicines
  • Micah Haskell-Hoehl, Founder, Healing Equity and Liberation (HEAL)
  • Sutton King, MPH, President, Urban Indigenous Collective; Trustee and Impact Advisor, Journey Reciprocity Trust, Journey Collab; Indigenous Program Officer, Riverstyx Foundation

Sponsored by the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School.